Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Trial of Screening and Ultra-Rapid Profiling to Enable Real-Time Neuro-Oncology Validation and Actionable Treatment Selection for Patients With Relapsed or Recurrent Rare Brain Tumors

NCT07851636 is registered in ClinicalTrials.gov with Adriana Fonseca as lead sponsor.

NCT NCT07851636
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07851636 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Trial of Screening and Ultra-Rapid Profiling to Enable Real-Time Neuro-Oncology Validation and Actionable Treatment Selection for Patients With Relapsed or Recurrent Rare Brain Tumors
Lead sponsor
Adriana Fonseca
Phase
Not applicable
Overall status
Recruiting
Start date
October 31, 2026
Completion date
October 31, 2032
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bcor itd sarcoma, cns sarcoma, foxr2-activated, mesenchymal tumor, plag-altered tumors, rare cns tumor